Home>Media>News Room

News Room

TCG Lifesciences Limited conferred with ‘Excellence Award’ by Institute of Economic Studies, New Delhi & MD Swapan Bhattacharya with ‘Udyog Rattan’

New Delhi, India - January 10, 2009 - TCG Lifesciences Limited has been conferred with 'Excellence Award'  and its Managing Director, Swapan Bhattacharya with ‘Udyog Rattan’, by one of India’s premier research institutes ‘Institute of Economic Studies’ (IES)  for the outstanding achievements in the field of life sciences and contribution in India’s industrial development.

The awards were presented by HE B. P. Singh, Governor of Sikkim in the presence of Dr. Bhishma Narain Singh, former Governor of Tamil Nadu and Dr. G.V.G. Krishnamurthy, former Election Commissioner of India at the award ceremony in New Delhi.

Commenting on his achievement Mr. Bhattacharya said “I am honored to receive this prestigious award and I humbly accept it on behalf of the entire TCG Lifesciences family without whose dedicated and relentless team effort this achievement would not have been possible. I would like to thank IES for bestowing this honor.”

The ‘Institute of Economic Studies’ was established in 1980 by a group of economists, parliamentarians and industrialists. The organization works on studying various aspects of economy and economic development. The institute closely monitors various facets of economy and individual contribution of various companies and business leaders.

TCG Lifesciences Limited (formerly “Chembiotek Research International”) is a leading research services and informatics company with operations in India, Europe, Japan and the United States. It is part of The Chatterjee Group, a global investment conglomerate headquartered in New York. TCG Lifesciences Limited (“TCGLS”) collaborates to service the multi-disciplinary research efforts of global pharmaceutical and biotechnology companies through its 3 units Chembiotek (Discovery Research), Clininvent (Clinical Research Solutions) & Labvantage (Enterprise Informatics).

TCGLS offers a new paradigm of cutting edge drug discovery and development platform whereby the R&D process is seamlessly transitioned from ‘bench to bedside and back’, and laboratory data easily accessed and managed across the product development lifecycle. Its relationships with the customers and collaborators span from specific solutions and sourcing services to integrated projects across multiple domains to complete translational research programs.

Mr. Bhattacharya
, is a B.Tech from the Indian Institute of Technology, Kharagpur, an M.S. from Virginia Polytechnic Institute and State University, and a M.B.A. from Kellogg School of Management, Northwestern University. He was presented the Lester Cunningham Award for academic excellence at Northwestern.

Mr. Bhattacharya joined ‘The Chatterjee Group’ (TCG) in 1995 and has played a key role in expanding TCG's investments in India, by identifying and developing opportunities, negotiating and closing transactions and monitoring investment performance. In 2001, he took the responsibility to expand TCG’s life sciences business in India and has successfully positioned TCG Lifesciences as one of the leading life sciences contract research services and informatics organization. He is also on the Board on various TCG companies. Mr. Bhattacharya is also Co-Chair of the National Biotech Committee formed by FICCI.


 

Back to News Section

Contact Us
Corporate Affairs and Communications:
media@tcgls.com